Ozempic, Wegovy linked to increased risk of blinding eye condition

New research suggests a link between popular diabetes and weight loss medications Ozempic and Wegovy and an uncommon eye condition that can lead to blindness. The research found semaglutide medications were significantly more likely to lead to the illness NAION, which leads to a reduction in blood flow to the optic nerve, resulting in sudden vision loss.